. Author manuscript; available in PMC: 2011 Jun 1.

Published in final edited form as: Eur Urol. 2009 Oct 17;57(6):1030–1038. doi: 10.1016/j.eururo.2009.10.020

Table 4.

Associations among proposed grouping, pathologic disease stage, pretreatment Gleason score, and pretreatment presence of cribriform pattern and/or intraductal spread

Pathologic stage^*	Group A or B	Group C
Higher than ypT2	10	63
ypT2	22	20
Pretreatment biopsy Gleason score^†
7	10	23
>7	22	60
Cribriform pattern or intraductal spread in pretreatment biopsy^‡
Present	6	51
Absent	16	12

p < 0.0001 by Fisher exact test; “y” signifies preoperatively treated tissue.

^†

p = 0.65 by Fisher exact test.

^‡

p <0.001 by Fisher exact test in 85 of 115 available biopsy slides.